![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 34, 24232-24240, August 20, 1999
From the Institute of Genetics, University of Cologne,
D-50931 Koeln, Germany
Integration of foreign DNA into an established
host genome can lead to changes in methylation in both the inserted DNA
and in host sequences and potentially alters transgene and cellular transcription patterns. This work addresses the questions of what factors influence de novo methylation, and whether the
integration site or inserted DNA can affect de novo
methylation. Homologous recombination was used to integrate foreign DNA
into a specific gene, B lymphocyte kinase (BLK), in mouse embryonic
stem (ES) cells. Two plasmids were chosen for integration; one
contained the adenovirus type 2 E2AL promoter upstream of the
luciferase reporter gene, and the second carried the early SV40
promoter. The methylation patterns were analyzed using
HpaII and MspI restriction endonucleases for
both homologously recombined and randomly integrated foreign DNA in the
ES cell clones.
Upon homologous reinsertion of the BLK gene into the genome of mouse ES
cells, methylation patterns in this gene were reestablished. In DNA
segments adjoined to the BLK gene, the de novo patterns of
DNA methylation depended on the viral sequences in these clones and on
the locations of the inserts, i.e. on whether the
insertions resulted from homologously recombined or randomly integrated
foreign DNA. In homologously recombined DNA, sequences carrying the
adenovirus type 2 promoter were heavily methylated, and those with an
SV40 promoter and an SV40 enhancer element remained unmethylated or hypomethylated. Upon removal of the enhancer element, these inserted constructs also became heavily methylated. In addition, all randomly integrated constructs were heavily methylated independently of the
promoter and enhancer element present in the construct. These results
indicate that modes and sites of integration as well as the inserted
nucleotide sequence, possibly promoter strength, are factors affecting
de novo methylation.
Specific patterns of DNA methylation, an epigenetic modification
in the mammalian genome (1), have been shown to affect gene expression
(2-5). DNA methylation is involved in a number of regulatory
mechanisms, such as imprinting (6, 7), X chromosome inactivation (8),
carcinogenesis (9-11), and embryonic development (12). Adenovirus
(Ad)1 DNA has been used as a
model system to study the effects of foreign DNA integration and
methylation on host and Ad gene expression (2, 13-16). The Ad genome
is 34-36 kb in size and consists of a linear, double-stranded DNA
molecule with a 55-kDa protein covalently attached at either 5'
terminus. When this virus replicates in permissive cells, the
replicated genome is not methylated (17, 18). However, when the virus
DNA integrates into the host genome, as in Ad-induced tumor cells or in
Ad-transformed cells, the viral genome becomes methylated by a de
novo mechanism (19-21). Frequently, multiple copies of Ad DNA are
integrated at many sites in nontandem arrays in the host genome, but
there seems to be a preference for sites with patchy homologies at the
junctions between cellular and viral DNA (15, 16, 22, 23). When
adenovirus (foreign) DNA is inserted into the mammalian genome, there
are changes in the methylation patterns of the flanking sequences due
to the position of the integration and/or the inserted DNA sequences. After Ad integration, the methylation in the flanking host sequences can be altered (24) as well as other more remote genomic sequences such
as major histocompatibility complex class I, Ig Cµ and intracisternal A particle DNA sequences (25). In addition, when only bacteriophage Methylation of Ad or any other foreign DNA integration may be affected
by the site of integration in the host genome. In addition, position
effects on de novo methylation have been shown in several different systems including cell lines containing a variety of transgenes (27, 28) and in transgenic mouse models (29, 30).
Detailed analyses of DNA methylation and expression always reveal a
more complex situation, because transgenic cell lines usually contain
multiple copies of the gene of interest at different positions or in
concatenated forms in the host genome, which is a common result of
random integration. In order to understand better the regulation of
de novo methylation, homologous recombination was used to
insert different foreign DNAs into one site in the genome of mouse
embryonic stem cells. The results show that random integration appears
to promote de novo methylation. For homologous recombination
with one allele of the same insert in the same cell type, the original
methylation pattern for the genomic sequence is reestablished. However,
for foreign DNA the extent of de novo methylation depends on
the newly integrated sequence.
Plasmids Used for Homologous Recombination and for DNA
Probes--
AdBLK and SVBLK (Fig. 1) were constructed to perform
homologous recombination in mouse embryonic stem (ES) cells within the B lymphocyte tyrosine kinase (BLK) gene located on mouse chromosome 14 (31). The two constructs contain from the 5'-end, a 4.1-kb BLK left
genomic fragment from the HindIII site in intron 1' to the
BamHI site in intron 3, the phosphoglycerate kinase (Pgk-1; Ref. 32) promoter upstream of the neomycin gene, a viral promoter upstream of the luciferase gene, and a 3.3-kb BLK genomic fragment from
the BamHI site in intron 3 to the EcoRV site in
exon 6 (Fig. 1). In addition, the thymidine kinase gene with the HSV-1
promoter was also present within the plasmids, but upon homologous
recombination and selection with gancyclovir it would not be
integrated. The BLK 5'- and 3'-genomic fragments were a gift of Gemma
Texido and Alexander Tarakhovsky (University of Cologne, Germany). The
numbering of the BLK exons is according to published data (33). The
neomycin gene with the Pgk-1 promoter was derived from a published
source (34). The luciferase gene was cloned from the PGL2 control
vector (Promega). The only difference between these two plasmids, AdBLK and SVBLK, is in the luciferase promoter region (Fig. 1A).
The AdBLK construct contains Adluc with the adenovirus type 2 (Ad2) E2A
late promoter upstream of the luciferase gene (35). The SVBLK contains
SVluc with both the SV40 early promoter 5' of the gene and the SV40
enhancer at the 3'-end derived from the PGL2 control vector (Promega).
This enhancer contains both the 72- and 21-bp repeats. A third plasmid,
SVpBLK, has been constructed that contains SVluc without the SV40
enhancer sequences at the 3'-end.
An additional BLK fragment, called BLK-out, was used to determine which
clones contained homologously recombined DNA within the BLK gene
(provided by Gemma Texido and Alexander Tarakhovsky), since this part
of BLK was not present in any of the constructs used for transfection
into ES cells. The BLK-5'ab probe is the fragment between the
ApaI site in exon 2 and the BamHI site in intron
3, while the BLK-3'xb probe is the DNA fragment from the same
BamHI site to the XbaI in intron 4. The Adluc
probe is the XhoI to SalI DNA fragment (3201 bp)
of pAd2E2AL-LUX (35), and the same fragment was isolated from
PGL2-control (Promega) to obtain the SVluc probe (3160 bp) (Fig.
1B). The neomycin (neo) probe is the 614-bp DNA
fragment from BsmI to DdeI, which contains only
the neomycin sequence.
Cell Culture--
The embryonic stem cell clone BL/6-III from
the C57BL/6 inbred mouse strain (36) and the clones derived from this
parental clone were grown in Dulbecco's modified Eagle's medium with
Glutimax (Life Technologies, Inc.), 15% fetal calf serum, 1 mM sodium pyruvate (Life Technologies), 1× non essential
amino acids (Life Technologies), 0.1 mM
Gene Transfer, DNA Isolation, and Southern Blot
Analyses--
All plasmids used for transfection experiments were
propagated in Escherichia coli strain XL1-Blue MRF'
(McrA
Within the BLK flanking sequences and the luciferase and neomycin
regions, methylation levels were determined by cleaving 30 µg of each
DNA sample first with BamHI (10 units/µg DNA) for 5 h
followed by either HpaII or MspI (10 units/µg)
overnight. Both HpaII and MspI cleaved DNA at
5'-CCGG-3' sites. HpaII is methylation-sensitive and
therefore cannot cleave this site when the internal (3') C is
methylated. When the samples were cleaved with BamHI only,
10 µg of genomic DNA was used.
Some of the membranes were also exposed to the BAS-IIIS or BASMP
phosphor image screen (Fuji), processed in the phosphor imager FUJIX
BAS 1000 (Fuji), and analyzed with IPgel 1 software (Signal Analytics).
Luciferase Expression--
Protein was extracted from the ES
cell clones by standard protocols (Promega). Briefly, cells were washed
twice with MT-PBS, scraped with a rubber policeman with MT-PBS, and
transferred to an Eppendorf tube. The cells were washed and then
resuspended in 1× lysis buffer (25 mM Tris-phosphate, pH
7.8, 2 mM EDTA, 2 mM dithiothreitol, 10%
glycerol, 1% Triton X-100). All samples were frozen once, centrifuged,
and then assayed three times each with the luminometer Lumat LB 9501 (Berthold, Bad Wildbad, Germany) using the luciferase substrate and
buffer system (Promega). In addition, protein concentrations were
determined (42) for each sample to normalize the data to relative light
units (RLU) per µg of protein.
Homologous Recombinant and Randomly Integrated DNA in ES
Clones--
Two different DNAs, AdBLK or SVBLK, were electroporated
into mouse ES cells to obtain homologous recombinants and to
investigate whether specific DNA sequences can affect de
novo methylation. ES cells were chosen as the host, since they
possess a de novo methylation mechanism (43-45). The BLK
gene was chosen as the target, and both the genomic BLK DNA fragments
and the ES cells (BL/6-III) are derived from the same mouse strain,
C57BL/6. The plasmids, AdBLK and SVBLK, contain the neomycin and
luciferase genes and are flanked by two BLK genomic DNA fragments.
Therefore, after HR, the foreign DNA segment is inserted within intron
3 of the BLK gene (Fig. 1B).
Two types of HR clones were obtained after electroporation into ES
clones, and they differ only within the luciferase region. The A clones
carry Adluc, the Ad2 E2A late promoter 5' of the luciferase reporter
gene (Fig. 1A, Table I, left
side). This promoter has been shown to be inhibited by
sequence-specific methylation (46, 47). The S clones have SVluc with
the SV40 early promoter 5' of the luciferase coding sequence and at the 3'-end the SV40 enhancer element containing the 72- and 21-bp repeats
(Fig. 1A, Table I, right side).
Genomic DNA was obtained from about 40 different ES clones from each
transfection to determine which clones had incorporated the neomycin
and luciferase sequences within the expected BLK site by homologous
recombination and which clones contained part or all of these sequences
in other locations due to random integration events. The genomic DNA
was cleaved with HindIII, and the fragments were separated
by electrophoresis on a 0.8% agarose gel for Southern blot analysis.
Two different probes were used to analyze the location of the inserts
and the presence of the luciferase sequence (Fig. 2). In Fig. 2A, the DNA on the
membrane was probed with the EcoRV-HindIII fragment of BLK, designated BLK-out, since this BLK sequence was outside the region used for homologous recombination (Fig.
1B). For the Adluc-containing clones (e.g. A1)
and for the SVluc-containing clones (e.g. S4), the expected
8.5-kb fragment for the endogenous allele is detected as well as the
7.9-kb fragment for the homologous recombinant allele. Using the
luciferase sequence probes (Fig. 1B, Adluc or SVluc), the
expected size fragment of 7.9 kb is also detected and is the same size
as that present with the BLK-out probe (Fig. 1B), since
these fragments contain both the BLK and the luciferase sequences. When
the DNA on the same membrane is probed with left and right BLK
fragments, all BLK fragments are present as expected, the endogenous
allele (8.5 kb) and the two fragments from the HR allele (5.9 and 7.9 kb).
In addition to the clones that contain foreign DNA homologously
recombined within intron 3, a number of ES clones with randomly integrated foreign DNA have been isolated. All RI clones are designated with an asterisk. No 7.9-kb band is detected in the DNA of
these clones when BLK-out is used as the probe. In addition, an off size DNA fragment is visible when the DNA on the membrane is hybridized with the luciferase probe. Table I lists the Adluc-containing clones,
referred to as A clones, and the SVluc-containing clones, referred to
as S clones, which have been chosen for further studies. At the time
points indicated, genomic DNA was extracted for Southern blot analyses,
and in addition, protein extracts were prepared at different times to
determine the luciferase activity in the different cell populations at
various passages. In this study, we have analyzed a number of different
ES clones to ascertain representative sampling.
Luciferase Expression of ES Clones--
For the protein extracts
of all HR A and S clones, the RLU/µg of protein decrease with initial
passaging as seen in Fig. 3. Throughout
passaging, the S clones exhibit 10-50-fold higher RLU/µg of protein
than the A clones (Fig. 3, compare A and B). In
addition, the constitutive RLU/µg of protein in later passages is
higher for the S clones than for the A clones. Both sets of A* and S* clones with RI foreign DNA exhibit a 100-fold reduction or no luciferase activity at all from early on (passage 3) to the latest passage analyzed (passage 31; data not shown). After an initial drop in
luciferase expression, both the A and S clones maintain a constitutive
level even to late passages. We have not related these expression
levels to the patterns of DNA methylation, because correlations between
promoter activity and DNA methylation have not been the primary
objective of this study. Moreover, in the SV40 promoter there is no
HpaII site that would allow investigations by restriction
with HpaII and MspI.
Upon Homologous Reintegration, the 5'- and 3'-Flanking BLK
Sequences Reestablish 5'-CCGG-3' Methylation Patterns Similar to Those
in the Endogenous BLK Alleles--
For the analyses of methylation
patterns, all genomic DNA samples were cleaved with BamHI to
separate the BLK sequence from that of the foreign DNA (Fig.
1B). In this way, each DNA sequence was analyzed
individually. In addition, one of the two restriction endonuclease
isoschizomers MspI or HpaII was used to analyze
the DNA methylation levels. Unlike MspI, HpaII is
unable to cleave the sequence 5'-CCGG-3' when the internal (3') C is
methylated. Therefore, the difference in DNA fragment patterns
generated with these two endonucleases represents differences in DNA
methylation at 5'-CCGG-3' sites. When control genomic DNA (C
in Fig. 4) from untransfected cells is
cleaved with BamHI (lanes B), a single fragment is detected as expected when BLK-3'xb was used as a probe (Fig. 4, C, lanes B). MspI
cuts the DNA into much smaller fragments (lanes
M) which are not resolved by electrophoresis on a 0.8% agarose gel. There are larger molecular mass fragments present after
BamHI/HpaII cleavage (Fig. 4, lanes
H) as compared with BamHI/MspI
cleavage (lanes M). This finding demonstrates
that many HpaII sites within the BLK 3'-flanking sequence
(see Fig. 1B) are methylated. A comparison of the control
(C) DNAs to the DNAs from A and S clones reveals that the
HpaII patterns are very similar or identical (Fig. 4,
H lanes). Moreover, for a given DNA fragment
within an H lane of any of the ES clones, the
relative intensities are similar as for the corresponding bands in the control DNA H lane (Fig. 4, e.g.
C and A17 or S11; H
lanes). This similarity of HpaII patterns within
the BLK 3'-flanking sequence has been seen for all A and S clones
analyzed. With a few exceptions, similar results have also been
obtained for the 5'-flanking BLK sequence (data not shown). First, as
in the BLK 3'-flanking sequence for the control (C) DNA from
untransfected ES cells, there are many larger molecular mass fragments
present in the H lanes as compared with the
M lanes. This finding again implies that the BLK
5'-flanking sequences are methylated. The HpaII patterns of DNA from one clone, S4, show some differences in banding patterns of
the 5'-flanking sequence, both between passages (p6 to p20) and
compared with DNA from the parental untransfected ES cells (data not
shown). Slight differences in the HpaII patterns may not be
detectable, since the 5'- and 3'-BLK probes hybridize to both the
endogenous and HR allelic fragments. We conclude that the homologously
reintegrated BLK sequences are remethylated in 5'-CCGG-3' patterns very
similarly to those of the endogenous BLK gene.
A and S Clones Develop Different Methylation Patterns in the
Luciferase Region--
The luciferase regions of the A and S clones
were analyzed to investigate whether foreign DNA sequences influence
de novo methylation after their integration. Fig.
5 shows the autoradiograms of Southern
blots of genomic DNA isolated at different passages for a number of the
A clones. The entire luciferase region including the Ad promoter was
used as the probe (Adluc; Fig. 1A). As expected, there is no
detectable hybridization to the DNA in the control lane (C,
lanes B, M, and H).
However, for the DNAs from the A clones, the expected 5-kb fragment is
detected after BamHI cleavage (B
lanes). There are 15 5'-CCGG-3' sites (vertical
lines in Fig. 1A) that can be differentially
methylated. Different cleavage patterns are generated by
MspI versus HpaII (M and
H lanes, respectively). Upon HpaII
cleavage of the DNA from all passages analyzed, very large
HpaII fragments, ranging in size up to the 5-kb
BamHI fragment in the DNA of many clones (e.g.
A4, A5, A8, A16, and A18) are generated (Fig. 5).
For the S clones, a very different trend is seen. SVluc (Fig.
1A) was used as a probe to determine the methylation
patterns of these clones. The DNA samples of only a few clones, such as S5 and S11, exhibit larger HpaII fragments at molecular
masses higher than those for the MspI fragments. For the
majority of the S clones, the MspI and HpaII
cleavage patterns are quite similar (Fig.
6, M versus
H lanes). These data demonstrate that the
HpaII patterns of DNA from A and S clones are strikingly
different. The foreign luciferase gene thus becomes extensively
de novo methylated when it is located downstream of the Ad2
promoter but remains unmethylated or hypomethylated when the same gene
is within the context of the SV40 promoter and enhancer.
Both the A and S clones were passaged for an extended period of time to
determine the regulation of de novo methylation for a given
site in the genome, i.e. within the BLK gene. For the A and
S clones analyzed, once the HpaII pattern was established, it remained unchanged with passaging, e.g. A15 and S14
(Figs. 5 and 6). In addition, longer exposures were made, and phosphor images were analyzed that confirmed these results (data not
shown).
All Randomly Integrated Sequences Have a High Degree of Methylation
in the Luciferase Region--
As a control, genomic DNAs from a number
of A* and S* clones with randomly integrated DNA were also analyzed
(Fig. 7). In contrast to the A and S
clones with the HR foreign DNA, all HpaII patterns in
RI clones contained only very high molecular mass fragments
starting at 1 kb up to the size of the 5-kb BamHI fragment. These RI clones carried from about five to 15 copies of the foreign DNA. However, detailed mapping was not done, and the sites of integration remained unknown. We conclude that randomly
integrated foreign DNA becomes extensively de novo
methylated.
The DNAs in the A and S Clones Differ in Their Methylation Patterns
in the Neomycin Gene--
Since the HpaII patterns for the
DNAs from the homologously recombinant clones with Ad2 or SV40
promoters in front of the luciferase gene are strikingly dissimilar,
the neomycin regions just 5' of the luciferase sequence have also been
analyzed in DNA from the same ES clones. Since the nucleotide sequence
of the inserted foreign DNA is identical in both sets of these HR clones, the same neomycin probe was used to determine the
HpaII cleavage patterns. In the control lanes (Fig.
8, C, lanes
B, H, and M), there are no detectable
bands at the sizes expected for the neomycin fragments. For the DNAs
from the A clones, the HpaII patterns (H
lanes) show various intensities of molecular fragments larger than the MspI patterns (M
lanes) (e.g. clones A5, A8, and A18) (Fig. 8). In
addition, there are clones such as A17 and A15 that have similar
MspI and HpaII patterns (M and
H lanes). There is a range of HpaII
patterns that differ in relative intensities of the larger molecular
mass fragments within a given H lane. The A
clones with larger HpaII fragments in the luciferase region also have higher amounts of larger HpaII fragments in the
neomycin region. Those clones, whose DNAs exhibit intermediate DNA
methylation in the luciferase region, have very low to undetectable
levels in the neomycin region. Hence, there appears to be a congruence in the levels of de novo methylation between the luciferase
and neomycin regions; the DNAs from clones that are strongly methylated in the luciferase region are also more highly methylated in the neomycin region.
If this correlation holds for the S clones as well, we would expect
very low levels of methylation in the neomycin regions, since there is
little to no methylation present in the luciferase sequence. As
expected for the S clones, the MspI and HpaII
patterns are quite similar (Fig. 9,
compare the M and H lanes)
(i.e. no or very low methylation is detected).
The DNA in All RI Clones Has a High Degree of Methylation in the
Neomycin Region--
Next, the neomycin region was investigated for
differences between the HpaII patterns of the RI A* and S*
clones. As observed in the luciferase region (Fig. 7), only very large
molecular mass fragments are detected in the HpaII patterns
of the DNA on Southern blots hybridized with the neomycin probe (data
not shown). These data confirm that all segments of the randomly
integrated foreign DNA become extensively de novo methylated
both in the luciferase and neomycin genes.
DNA Methylation Patterns and Luciferase Expression of the SVpBLK
Clones Lacking the Enhancer Element--
Sp1 sites have been
implicated in inhibiting de novo methylation of
5'-CG-3'-rich regions (48, 49) and in increasing gene expression (50).
The Sp1 sites could negatively affect the de novo
methylation of the entire luciferase and neomycin genes within the S
clones. To test this hypothesis, new ES clones were established using
another plasmid, SVpBLK, which contains SVluc as in the S clones, but
without the SV40 enhancer at the 3'-end (see Fig. 1A). The
21- and 72-bp repeats that are part of the enhancer were also removed.
In contrast to the HR clones from the S group, these new SVp clones (HR
and RI clones) have genomic DNA that is not completely cleaved with
HpaII as seen with the A clones (data not shown). These
results indicate that the DNA has become highly de novo methylated in all ES clones lacking the enhancer and the Sp1 sequences. While promoter strength is probably a factor influencing de
novo methylation, these data imply that cis-acting sequences can
inhibit de novo methylation over several kb, as suggested
elsewhere (51).
The luciferase expression from the SVp HR clones with the highly
de novo methylated sequences is at least 100-fold lower
(10-25 RLU/µg of protein) as compared with the original S clones
(data not shown). Similarly, the SVp RI clones show very low to no
luciferase activity (data not shown).
De Novo Methylation after Release and Reestablishment of
Selection--
Can this experimental mode lead to the high levels of
methylation in the Adluc-containing clones? An early passage of cell clone A8 was used for the release and reselection experiment and passaged either in the presence or the absence of G418. Genomic DNA
from both clonal sublines was then isolated after 8 days. A comparison
of the two sets of A8 DNA shows that there is no change in the
methylation patterns in either the luciferase or neomycin region. This
finding suggests that the expression of neomycin does not play a role
in the inhibition or activation of de novo methylation of
its sequence or of the luciferase gene.
De Novo Methylation of Foreign DNA Is Dependent on Several
Factors--
For many problems in molecular biology, it is of
considerable interest to understand the mechanisms and the regulation
of de novo methylation of foreign DNA that has been inserted
into an established mammalian genome, haphazardly or by experimental design. One of the major unresolved questions about the mechanism of
de novo DNA methylation addresses the factors determining
the sites and extent of foreign DNA methylation upon insertion into the
recipient genome. The following factors could be of relevance: (i) the
site of insertion, (ii) the nucleotide sequence of the foreign DNA,
(iii) specific motifs in the foreign DNA, (iv) the timing of the
insertion event relative to the cell cycle, and (v) promoter strengths
and/or elements (e.g. enhancers) in the inserted foreign DNA.
We have devised a series of experiments in which part of the murine BLK
gene on chromosome 14 was reinserted into one of its authentic allelic
genomic sites by homologous recombination. Mouse ES cell clones with
the reinserted DNA in the correct position were selected. ES clones
with the BLK DNA inserted into randomly targeted positions were also
analyzed as controls. Foreign DNA sequences have been attached to the
BLK gene in the constructs used in the electroporation-driven
transfection experiments and have been placed inside the endogenous BLK
gene (Fig. 1B). Three different constructs were transfected
into ES cells to create three types of ES clones. In all of them, the
neomycin gene has the same promoter, phosphoglycerate kinase, but the
luciferase gene has a different promoter and/or enhancer sequence in
each construct. The A clones carry the luciferase gene under the
control of the Ad2 E2A late promoter. For the S clones, the SV40 early promoter is located 5' of the luciferase gene, and the SV40 enhancer sequences are located 3'.
The DNAs in all of the A clones become de novo methylated in
both the luciferase and neomycin genes, while the S clones stay hypomethylated even after 30 passages. The third type of ES clone, SVp,
is identical to the S clone, except that it contains the promoter
without the SV40 enhancer sequences at the 3'-end. Unlike the original
S clones, these HR clones become de novo methylated within
the luciferase and neomycin sequences at levels as seen for the A
clones. These results indicate that the enhancer element, containing
the 21- and 72-bp repeats, is required to inhibit de novo
methylation within the entire luciferase and neomycin regions. The
protection of sequences from de novo methylation may be due to factors binding these sequences, e.g. multiple Sp1 sites
that are present in the enhancer sequence. Inhibition may occur at sites where there is an interaction between the promoter and the enhancer element within the transgene. In addition, the strength of the
SV40 promoter, as compared with the Ad2 E2A late promoter, could also
be a factor.
The DNAs from all of the RI clones in our study, regardless of the
foreign sequence integrated, become highly methylated. These sequences
can be recognized as foreign and may activate a host defense de
novo methylation reaction (52, 53). Thus, the enhancer element
that is present in some of the RI clones (data not shown) or promoter
strength does not suffice to inhibit de novo methylation
after random integration. Topologically correct insertion, as after
reintegration by HR, apparently does not activate this defense
mechanism. Therefore, our data indicate that genome location plays a
major role in the regulation of de novo methylation.
The results presented in this report lead to the following conclusions.
(i) The homologously recombined BLK sequence becomes remethylated in
patterns very similar to the authentic preexisting cellular patterns of
the endogenous alleles. (ii) Randomly integrated foreign DNA becomes
very heavily methylated. Thus, position and vicinity effects including
sequence and structure of the insert must be of considerable importance
in determining de novo methylation patterns. (iii) The
extents of de novo methylation of the foreign luciferase and
neomycin genes reintegrated homologously with the BLK sequence depend
on the sequences present in these constructs and/or on promoter
strength. The early SV40 promoter with the enhancer sequences seems to
prohibit de novo methylation, and the luciferase gene is
expressed in the transgenic ES cells. Constructs under the control of
the E2A late promoter of Ad2 DNA or under the SV40 promoter without the
enhancer elements become extensively de novo methylated even
in the authentic BLK position, and luciferase expression is reduced.
However, in randomly integrated constructs the nature of the promoter
or presence of the SV40 enhancer element is not decisive for de
novo methylation. Thus, their role in determining de
novo methylation may not be fundamental, at least not in randomly integrated foreign DNA. (iv) Removal and addition of the selective drug
G418 does not alter the methylation levels of the examined DNA
sequences in the ES clones that contain the Ad2 E2A late promoter. (v)
After homologous recombination into BLK genes, nucleotide sequences in
the transgenic foreign DNA can affect de novo methylation. One can ponder the possibility that promoters with their
transcriptional potential in transgenic sequences within a specific
chromatin arrangement interact with the cellular machinery that is
responsible for de novo methylation or its inhibition.
A Working Model--
The mechanism of de novo
methylation of foreign DNA inserted into an established mammalian
genome cannot yet be explained in detail. De novo
methylation may be related to an ancient cellular defense system
targeted against foreign DNA (52, 53). In the present study, we have
investigated some of the factors influencing de novo
methylation when an authentic cellular DNA sequence is reinserted into
the mouse genome at different locations. The experimental approach
chosen exposes the authentic unmethylated BLK sequence to the de
novo methylation system in two different ways. In one set of
experiments, the BLK DNA has been reinserted into its original chromosomal location by homologous recombination. Alternatively, upon
random integration by heterologous recombination, the BLK and adjacent
sequences are located at several randomly selected sites where they are
apparently recognized as foreign by the de novo methylation
machinery. In the latter context, promoter strength and presence or
absence of the SV40 enhancer sequence seem to be of lesser importance
in determining the extent of de novo methylation.
As a working model, we are pursuing the possibility that the enzymatic
process of de novo methylation recognizes and is dependent upon the specific chromatin structure at the site of an individual gene
or DNA segment. Thus, the endogenous BLK DNA at its authentic site or
the same DNA inserted at randomly chosen locations would look very
different to the DNA methyltransferase system. When the BLK gene and
adjoining sequences in the construct are homologously reinserted into
one of the authentic allelic BLK positions on mouse chromosome 14, the
preexisting chromatin configuration can be reconstituted. Under these
conditions, the de novo methylation system then imprints the
methylation pattern specific for the BLK locus that had preexisted
prior to the transfection of ES cells. In contrast, after random
integration, when the BLK construct arrives in an alien position with a
locus-specific, but not BLK-typical, chromatin arrangement, a different
pattern of de novo methylation will be imposed upon the
integrated DNA that is recognized as foreign in this location with a
heterologous sequence context. Of course, this model still leaves the
question unanswered of how de novo methylation and chromatin
structure are interdependent. Differences in the accessibility of
individual 5'-CG-3' dinucleotides to the DNA methyltransferase system
may be one of the important parameters.
We thank our colleagues at the Institute of
Genetics, Werner Müller, and Alexander Tarakhovsky, for
advice and Raul Torres and Ralph Kühn for help with the ES techniques.
*
This research was supported by European Union Grant EN AX
101805 and Deutsche Forschungsgemeinschaft Grant SFB274-A1.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Inst. of Genetics,
University of Cologne, Weyertal 121, D-50931 Koeln, Germany. Tel.:
49-221-470-2386; Fax: 49-221-470-5163; E-mail:
doerfler@scan.genetik.uni-koeln.de.
The abbreviations used are:
Ad, adenovirus;
Ad2, adenovirus type 2;
ES, embryonic stem;
BLK, B lymphocyte kinase;
kb, kilobase pair(s);
bp, base pair(s);
HR, homologously recombined;
RI, randomly integrated;
RLU, relative light unit(s).
Factors Affecting de Novo Methylation of Foreign DNA
in Mouse Embryonic Stem Cells*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
DNA has been stably integrated into cellular DNA, again intracisternal A particle DNA sequences have shown changes in their methylation patterns (26).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-mercaptoethanol, and conditioned medium containing leukemia inhibitory factor (provided by the laboratory of Klaus Rajewsky, University of Cologne, Germany). In some experiments, penicillin and
streptomycin were added. A modified solution was used to wash the
cells, MT-PBS (4 mM
NaH2PO4·H2O, 16 mM
Na2HPO4·2H2O, 150 mM NaCl) (37). Cells were propagated on tissue culture plastic dishes or
flasks at 37 °C, 7.5% CO2, with 85-90% humidity.
Medium was replaced every day, and the cells were passaged every 2-3 days to minimize differentiation of the cells (36).
, McrCB
, McrF
,
Mrr
, HsdR
), a derivative of XL1-Blue
(Stratagene). Amounts of 30 µg each of linearized plasmid DNA were
electroporated into 1-2 × 107 ES cells by using the
Bio-Rad Gene Pulser apparatus as described previously (38). Medium was
replaced daily. After 2 days, 300 µg/ml Geneticin (G418-sulfate; Life
Technologies), and 2 days later, 2 × 10
6
M gancyclovir (Syntex/Roche) was added to the mediun to
minimize the number of clones with random integration events (39).
Individual clones were isolated from day 10 to 12, transferred into
48-well plates, and transferred several days later to 24-well plates. After passaging the clones into larger dishes, no further selection (G418 or gancyclovir) was used. ES clone names begin with an A when
they were derived from transfection experiments using the construct
containing Adluc. Those clone names that begin with an S were derived
from the plasmid containing SVluc. ES clone names had an additional
"o" when they were isolated from plates having media with only
Geneticin. The first passage without selection is referred to as
passage 1 (p1). Each clone analyzed was passaged either into T75 or
T175 flasks to isolate DNA for Southern blot analyses by standard
procedures. The DNA samples were resuspended in TE (10 mM
Tris, pH 7.5, 1 mM EDTA, pH 8.0), and 10 µg of each sample was used to identify the clones that contained homologously recombined (HR) or randomly integrated (RI) foreign DNA (Table I). For
this analysis, the DNA was cleaved with HindIII (5 units/µg DNA) for 6 h at 37 °C. The fragments were separated
by electrophoresis on a 0.8% agarose gel in 1 × TAE (40 mM Tris acetate, 1 mM EDTA, pH 8.0) for about
15 h at 30-40 V. The gel was stained with ethidium bromide (1 µg/ml) for 10 min, destained in water, and then prepared for Southern
transfer (40, 41). Nylon Plus membranes (Qiagen) were used for the
downward transfer. The membranes were then exposed to x-ray film for
1-5 days.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (23K):
[in a new window]
Fig. 1.
Maps of the transgenes used in this study.
A, Adluc and SVluc luciferase regions present in the
homologously recombined ES clones shown in B. Adluc contains
the Ad 2 E2A late promoter upstream of the luciferase reporter gene
with the SV40 poly(A) signal (A) downstream. There are 15 MspI/HpaII sites within this sequence as shown by
vertical lines; three are within the promoter,
and one is within the polylinker 3' of the promoter. SVluc has the SV40
promoter upstream of the reporter gene and the SV40 enhancer 3' of the
poly(A) signal. There are only 12 MspI/HpaII
sites, with no sites in the promoter. B, genomic DNA after
homologous recombination of the neomycin and luciferase regions within
the BLK sequence. The exons (black boxes) are
numbered 1-6. The fragment from the
HindIII site 5' of exon 1 to an EcoRV within exon
6 was used for electroporation into C57BL/6 ES cells. When the
luciferase region contains Adluc, the ES clones are designated within
an A. When the region contains SVluc, the ES clones are designated with
an S. The HindIII and BamHI cleavage fragments
are shown below as thin lines; the DNA
probes are shown as thick lines.
Survey of all transgenic ES clones used in this study

View larger version (51K):
[in a new window]
Fig. 2.
Southern blot analyses (40) of the
DNAs from ES clones transgenic for AdBLK and SVBLK constructs. 10 µg of genomic DNA from each ES clone was cleaved with
HindIII. The fragments were electrophoresed through a 0.8%
agarose gel and transferred to a Qiagen Nylon Plus membrane. The DNA
probes were radiolabeled with
-32P to detect DNA
fragments after hybridization. In all figures, all ES clones
that contain Adluc DNA have designations beginning with an A, while
those clones that contain the SVluc DNA begin with an S (see Fig. 1).
A, BLK-out (map in Fig. 1B) was used as a probe
to detect two expected DNA fragments at 8.5 kb, representing the
endogenous BLK allele, and 7.9 kb for the homologously recombined
allele within intron 3 (see Fig. 1B). C
represents the control lane, ES cells that were not transfected.
B, the same membranes as in A were reprobed with
either Adluc (left panel) or SVluc
(right panel) to detect the 7.9-kb fragment
representing the luciferase region within BLK intron 3. C,
both membranes were reprobed again with BLK-in left and right together
to detect all BLK fragments integrated in the A and S clones. Randomly
integrated ES clones are marked with an asterisk. A
minus symbol represents clones that lack
detectable integrated foreign DNA.

View larger version (54K):
[in a new window]
Fig. 3.
Luciferase expression in the S and A
clones. Protein extracts were isolated, and luciferase activity
was measured with a Lumat LB 9501 luminometer (Berthold, Bad Wildbad,
Germany). Background levels were subtracted from all samples, and
protein concentrations were determined to normalize the data to RLU/per
µg of protein. Vertical bars represent S.D.
values.

View larger version (49K):
[in a new window]
Fig. 4.
Reestablishment of the endogenous methylation
patterns after homologous recombination. For Southern blot
analyses, 30 µg of genomic DNA from each clone at different passages
was cleaved with BamHI (B lanes) and then with either
HpaII (H lanes) or MspI (M lanes). Probe BLK-3'xb
(see Fig. 1B) was used to determine the methylation patterns
of the DNA from the transgenic ES clones as well as from the parental
ES cells (C) that had never been transfected. Both
HpaII and MspI cleave DNA at 5'-CCGG-3', but
HpaII is methylation-sensitive. Sites that are not cleaved
by HpaII are detected on the autoradiogram when DNA cleavage
fragments are present in an H lane that have
higher molecular mass as compared with the M lane
in the same passage. These larger fragments are due to methylation at
these sites.

View larger version (52K):
[in a new window]
Fig. 5.
The DNAs from the Ad sequence-containing ES
clones show a high degree of de novo methylation
within the luciferase region. For Southern blot analyses, 30 µg
of genomic DNA from each A clone was cleaved with BamHI
(B lanes) and then with either HpaII
(H lanes) or MspI (M
lanes). Probe Adluc (see Fig. 1, A and
B) was used to determine the methylation patterns within
this sequence of integrated DNA from the transgenic ES clones by
comparing the M and H lanes after each
passage.

View larger version (56K):
[in a new window]
Fig. 6.
The DNAs from the SV sequence-containing ES
clones show a low degree of de novo methylation within
the luciferase region. For Southern blot analyses, 30 µg of
genomic DNA from each S clone was cleaved with BamHI
(B lanes) and then with either HpaII
(H lanes) or MspI (M
lanes). Probe SVluc (see Fig. 1, A and
B) was used to determine the methylation patterns within
this sequence of integrated DNA in the transgenic ES clones by
comparing the M and H lanes after each
passage.

View larger version (53K):
[in a new window]
Fig. 7.
Randomly integrated DNAs in both the A and S
clones show a high degree of de novo methylation
within the luciferase region. For Southern blot analyses, genomic
DNA from each clone was cleaved with BamHI (B
lanes) and then with either HpaII (H
lanes) or MspI (M lanes).
Probes SVluc or Adluc (see Fig. 1, A and B) were
used to determine the methylation patterns of the S* or A* clones,
respectively, within this sequence of integrated DNA by comparing the
M and H lanes within each passage.
Randomly integrated ES clones are marked with asterisks. The
results for the DNAs from clones S18 and So5, which show low levels of
DNA methylation and are derived from HR experiments, are shown for
comparison.

View larger version (47K):
[in a new window]
Fig. 8.
The DNAs from Ad sequence-containing ES
clones show a varying degree of de novo methylation
within the neomycin region. Membranes carrying DNA from A clones
(see Fig. 6) were reprobed with neomycin (neo, Fig.
1B) to determine the methylation patterns in the neomycin
sequence of integrated DNA of the ES clones by comparing the
M and H lanes.

View larger version (46K):
[in a new window]
Fig. 9.
SV40 sequence-containing clones show low to
no de novo methylation within the neomycin
region. Membranes carrying DNA from S clones (see Fig. 7) were
reprobed with neomycin (neo, Fig. 1B) to
determine the methylation patterns in this sequence of integrated DNA
of ES clones by comparing the M and H
lanes within each passage.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Recipient of a fellowship from the Alexander von
Humboldt-Stiftung, Bonn, for part of the time of her stay in Koeln.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Holliday, R.
(1987)
Science
238,
163-170 2.
Doerfler, W.
(1983)
Annu. Rev. Biochem.
52,
93-124[CrossRef][Medline]
[Order article via Infotrieve]
3.
Razin, A.,
and Cedar, H.
(1991)
Microbiol. Rev.
55,
41-45
4.
Eden, S.,
and Cedar, H.
(1994)
Curr. Opin. Genet. Dev.
4,
255-259[CrossRef][Medline]
[Order article via Infotrieve]
5.
Kass, S. U.,
Pruss, D.,
and Wolffe, A. P.
(1997)
Trends Genet.
13,
444-449[CrossRef][Medline]
[Order article via Infotrieve]
6.
Li, E.,
Beard, C.,
and Jaenisch, R.
(1993)
Nature
366,
362-365[CrossRef][Medline]
[Order article via Infotrieve]
7.
Neumann, B.,
and Barlow, D. P.
(1996)
Curr. Opin. Genet. Dev.
6,
159-163[CrossRef][Medline]
[Order article via Infotrieve]
8.
Beard, C.,
Li, E.,
and Jaenisch, R.
(1995)
Genes Dev.
9,
2325-2334 9.
Chuang, L. S.,
Ian, H. I.,
Koh, T. W.,
Ng, H. H.,
Xu, G.,
and Li, B. F.
(1997)
Science
227,
1996-2000
10.
Laird, P. W.
(1997)
Mol. Med. Today
3,
223-229[CrossRef][Medline]
[Order article via Infotrieve]
11.
Ramchandani, S.,
Macleod, A. R.,
Pinard, M.,
von Hofe, E.,
and Szyf, M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
684-689 12.
Li, E.,
Bestor, T. H.,
and Jaenisch, R.
(1992)
Cell
69,
915-926[CrossRef][Medline]
[Order article via Infotrieve]
13.
Sutter, D.,
and Doerfler, W.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
253-256 14.
Kruczek, I.,
and Doerfler, W.
(1982)
EMBO J.
1,
409-414[Medline]
[Order article via Infotrieve]
15.
Doerfler, W.
(1993)
Prog. Nucleic Acids Res. Mol. Biol.
46,
1-36[Medline]
[Order article via Infotrieve]
16.
Doerfler, W.
(1996)
BBA Rev. Cancer
1288,
F79-F99
17.
Günthert, U.,
Schweiger, M.,
Stupp, M.,
and Doerfler, W.
(1976)
Proc. Natl. Acad. Sci. U. S. A.
73,
3923-3927 18.
Wienhues, U.,
and Doerfler, W.
(1985)
J. Virol.
56,
320-324 19.
Sutter, D.,
Westphal, M.,
and Doerfler, W.
(1978)
Cell
14,
569-585[CrossRef][Medline]
[Order article via Infotrieve]
20.
Vardimon, L.,
Neumann, R.,
Kuhlmann, I.,
Sutter, D.,
and Doerfler, W.
(1980)
Nucleic Acids Res.
8,
2461-2473 21.
Orend, G.,
Knoblauch, M.,
Kämmer, C.,
Tjia, S. T.,
Schmitz, B.,
Linkwitz, A.,
Meyer zu Altenschildesche, G.,
Maas, J.,
and Doerfler, W.
(1995)
J. Virol.
69,
1226-1242[Abstract]
22.
Deuring, R.,
Winterhoff, U.,
Tamanoi, F.,
Stabel, S.,
and Doerfler, W.
(1981)
Nature
293,
81-84[CrossRef][Medline]
[Order article via Infotrieve]
23.
Gahlmann, R.,
Leisten, R.,
Vardimon, L.,
and Doerfler, W.
(1982)
EMBO J.
1,
1101-1104[Medline]
[Order article via Infotrieve]
24.
Lichtenberg, U.,
Zock, C.,
and Doerfler, W.
(1988)
Virus Res.
11,
335-342[CrossRef][Medline]
[Order article via Infotrieve]
25.
Heller, H.,
Kämmer, C.,
Wilgenbus, P.,
and Doerfler, W.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5515-5519 26.
Remus, R.,
Kämmer, C.,
Heller, H.,
Schmitz, B.,
Schell, G.,
and Doerfler, W.
(1999)
J. Virol.
73,
1010-1022 27.
Jähner, D.,
and Jaenisch, R.
(1985)
Mol. Cell. Biol.
5,
2212-2220 28.
Guy, L.-G.,
Kothary, R.,
and Wall, L.
(1997)
Nucleic Acids Res.
25,
4400-4407 29.
Sasaki, H.,
Allen, N. D.,
and Surani, M. A.
(1993)
in
DNA Methylation: Molecular Biology and Biological Significance
(Jost, J.-P.
, and Saluz, H. P., eds)
, pp. 469-486, Birkhäuser Verlag, Basel
30.
Koetsier, P. A.,
Mangel, L.,
Schmitz, B.,
and Doerfler, W.
(1996)
Transgen. Res.
4,
235-244
31.
Kozak, C. A.,
Dymecki, S. M.,
Niederhuber, J. E.,
and Desiderio, S. V.
(1991)
Genomics
9,
762-764[Medline]
[Order article via Infotrieve]
32.
Boer, P. H.,
Potten, H.,
Adra, C. N.,
Jardine, K.,
Mullhofer, G.,
and McBurney, M. W.
(1990)
Biochem. Genet.
28,
299-308[CrossRef][Medline]
[Order article via Infotrieve]
33.
Dymecki, S. M.,
Zwollo, P.,
Zeller, K.,
Kuhajda, F. P.,
and Desiderio, S. V.
(1992)
J. Biol. Chem.
267,
4815-4823 34.
McBurney, M. W.,
Sutherland, L. C.,
Adra, C. N.,
Leclair, B.,
Rudnicki, M. A.,
and Jardine, K.
(1991)
Nucleic Acids Res.
19,
5755-5761 35.
Muiznieks, I.,
and Doerfler, W.
(1994)
FEBS Lett.
344,
251-254[CrossRef][Medline]
[Order article via Infotrieve]
36.
Ledermann, B.,
and Bürki, K.
(1991)
Exp. Cell Res.
197,
254-258[CrossRef][Medline]
[Order article via Infotrieve]
37.
Torres, R. M.,
and Kühn, R.
(1997)
Laboratory Protocols for Conditional Gene Targeting
, pp. 73-79, Oxford University Press, Oxford
38.
Liljeström, P.,
Lusa, S.,
Huylebroeck, D.,
and Garoff, H.
(1991)
J. Virol.
65,
4107-4113 39.
Mansour, S.,
Thomas, K.,
and Capecchi, M.
(1988)
Nature
366,
348-352
40.
Southern, E. M.
(1975)
J. Mol. Biol.
98,
503-517[CrossRef][Medline]
[Order article via Infotrieve]
41.
Koetsier, P. A.,
Schorr, J.,
and Doerfler, W.
(1993)
BioTechniques
15,
260-261[Medline]
[Order article via Infotrieve]
42.
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
43.
Jaenisch, R.,
Harbers, K.,
Jähner, D.,
Stewart, C.,
and Stuhlmann, H.
(1982)
J. Cell. Biochem.
20,
331-336[CrossRef][Medline]
[Order article via Infotrieve]
44.
Szyf, M.,
Tanigawa, G.,
and McCarthy, P., Jr.
(1990)
Mol. Cell. Biol.
10,
4396-4400 45.
Lei, H.,
Oh, S. P.,
Okano, M.,
Jüttermann, R.,
Goss, K. A.,
Jaenisch, R.,
and Li, E.
(1996)
Development
122,
3195-3205[Abstract]
46.
Langner, K. D.,
Vardimon, L.,
Renz, D.,
and Doerfler, W.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
2950-2954 47.
Weisshaar, B.,
Langner, K.-D.,
Jüttermann, R.,
Müller, U.,
Zock, C.,
Klimkait, T.,
and Doerfler, W.
(1988)
J. Mol. Biol.
202,
255-270[CrossRef][Medline]
[Order article via Infotrieve]
48.
Brandeis, M.,
Frank, D.,
Keshet, I.,
Siegfried, Z.,
Mendelsohn, M.,
Nemes, A.,
Temper, V.,
Razin, A.,
and Cedar, H.
(1994)
Nature
371,
435-438[CrossRef][Medline]
[Order article via Infotrieve]
49.
Macleod, D.,
Charlton, J.,
Mullins, J.,
and Bird, A. P.
(1994)
Genes Dev.
8,
2282-2292 50.
Machon, O.,
Strmen, V.,
Hejnar, J.,
Geryk, J.,
and Svoboda, J.
(1998)
Gene (Amst.)
208,
73-82[CrossRef][Medline]
[Order article via Infotrieve]
51.
Melton, D. W.,
Ketchen, A.-M.,
and Selfridge, J.
(1997)
Nucleic Acids Res.
25,
3937-3943 52.
Yoder, J. A.,
Walsh, C. P.,
and Bestor, T. H.
(1997)
Trends Genet.
13,
335-340[CrossRef][Medline]
[Order article via Infotrieve]
53.
Doerfler, W.
(1991)
Biol. Chem. Hoppe-Seyler
372,
557-564[Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Hoelzer, L. A. Shackelton, and C. R. Parrish Presence and role of cytosine methylation in DNA viruses of animals Nucleic Acids Res., May 1, 2008; 36(9): 2825 - 2837. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hochstein, I. Muiznieks, L. Mangel, H. Brondke, and W. Doerfler Epigenetic Status of an Adenovirus Type 12 Transgenome upon Long-Term Cultivation in Hamster Cells J. Virol., May 15, 2007; 81(10): 5349 - 5361. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schumacher and W. Doerfler Influence of in vitro manipulation on the stability of methylation patterns in the Snurf/Snrpn-imprinting region in mouse embryonic stem cells Nucleic Acids Res., March 5, 2004; 32(4): 1566 - 1576. [Abstract] [Full Text] [PDF] |
||||